Detalhe da pesquisa
1.
Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone-Inhibitory Effect of Octreotide after Growth Hormone-Releasing Hormone Stimulation.
J Pharmacol Exp Ther
; 379(3): 400-408, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34599040
2.
Design, synthesis, and biological evaluation of novel somatostatin receptor subtype-2 agonists: Optimization for potency and risk mitigation of hERG and phospholipidosis.
Bioorg Med Chem
; 49: 116424, 2021 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34626901
3.
Endogenous prostaglandin E2 inhibits aberrant overgrowth of rheumatoid synovial tissue and the development of osteoclast activity through EP4 receptor.
Arthritis Rheum
; 63(9): 2595-605, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21898865
4.
Discovery and SAR Studies of Orally Active Somatostatin Receptor Subtype-2 (SSTR2) Agonists for the Treatment of Acromegaly.
ACS Chem Neurosci
; 11(10): 1482-1494, 2020 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32315148
5.
Analysis of the mechanism regulating the stability of rat macrophage inflammatory protein-2 mRNA in RBL-2H3 cells.
J Cell Biochem
; 90(5): 976-86, 2003 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14624457